🔥🐔 BizChicken 🐔🔥
Companies Similar to OptiNose, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Aytu BioPharma, Inc.
Adzenys XR-ODT
Aytu Biopharma, Inc. is a specialty pharmaceutical company focused on developing and commercializing novel therapeutics and consumer healthcare products in the United States and internationally. They offer products for the treatment of ADHD, allergies, fluoride deficiency, cough, and insomnia.
Symbol: AYTU
Recent Price: $1.61
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mr. Joshua R. Disbrow
Sector: Healthcare
Employees: 102
Address: 373 Inverness Parkway, Englewood, CO 80112
Phone: 720 437 6580
Last updated: 2024-12-31
Lyra Therapeutics, Inc.
XTreo technology platform
Lyra Therapeutics, Inc. is a clinical-stage therapeutics company developing integrated drug and delivery solutions for ear, nose, and throat diseases using its XTreo technology platform. It focuses on product candidates like LYR-210 and LYR-220 for chronic rhinosinusitis.
Symbol: LYRA
Recent Price: $0.22
Industry: Biotechnology
CEO: Dr. Maria Palasis Ph.D.
Sector: Healthcare
Employees: 88
Address: 480 Arsenal Way, Watertown, MA 02472
Phone: 617 393 4600
Leadership
- Harlan W. Waksal, M.D., Executive Chairman
- Maria Palasis, Ph.D., President and Chief Executive Officer
- Jason Cavalier, Chief Financial Officer
- Robert Kern, M.D., Chief Clinical Advisor
- Ronan O’Brien, Chief Legal Officer
- Vineeta Belanger, Ph.D., Senior Vice President of Clinical Affairs
- Gloria Cosgrove, Senior Vice President of Quality
- Allison Nance, Senior Vice President of Regulatory Affairs
- Michael Altman, CFA, Managing Director, Perceptive Advisors
- Ann Merrifield, Life Sciences Advisor and Board Director
- Konstantin Poukalov, Managing Director, Perceptive Advisors
- Bradford Smith, Board Director
- Nancy L. Snyderman, M.D., Board Director
- Jim Tobin, Lead Independent Director
- Robert Langer, D.Sc., David H. Koch Institute Professor, Massachusetts Institute of Technology
- George Whitesides, Ph.D., Woodford L. and Ann A. Flowers University Professor, Harvard University
Last updated: 2024-12-31
Eyenovia, Inc.
Optejet
Eyenovia, Inc. is focused on developing therapeutic solutions for ophthalmic conditions using its proprietary microdose array print platform and Optejet delivery system. It targets conditions like progressive myopia, presbyopia, and mydriasis.
Symbol: EYEN
Recent Price: $0.11
Industry: Biotechnology
CEO: Mr. Michael M. Rowe
Sector: Healthcare
Employees: 57
Address: 295 Madison Avenue, New York, NY 10017
Phone: 917 289 1117
Leadership
- Charles Mather, Chairman of the Board
- Ellen Strahlman, MD, MS, Independent Director
- Sean Ianchulev, MD, MPH, Director
- Michael Geltzeiler, Independent Director
- Rachel Jacobson, Independent Director
- Ram Palanki, PharmD, Independent Director
- Michael Rowe, Director
Last updated: 2024-12-31
Halozyme Therapeutics, Inc.
ENHANZE drug delivery technology
Halozyme Therapeutics, Inc. is a biopharma technology platform company specializing in enabling subcutaneous delivery of biologics using its patented ENHANZE technology. The company operates in the United States and internationally, offering products such as Hylenex recombinant and developing treatments for various medical conditions including lymphomas and immunodeficiency disorders.
Symbol: HALO
Recent Price: $47.99
Industry: Biotechnology
CEO: Dr. Helen I. Torley M.B. Ch. B., M.R.C.P.
Sector: Healthcare
Employees: 373
Address: 11388 Sorrento Valley Road, San Diego, CA 92121
Phone: 858 794 8889
Last updated: 2024-12-31
Kenvue Inc.
Tylenol, Nicorette, Zyrtec, Neutrogena, Aveeno, OGX, Listerine, Johnson's, Band-Aid, Stayfree
Kenvue Inc. operates as a consumer health company worldwide, focusing on self-care, skin health and beauty, and essential health products under various iconic brands.
News | News | News | News | About | About | Contact | Careers | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Careers | Careers | Careers | Careers | Careers | Careers | Careers | About
Symbol: KVUE
Recent Price: $21.18
Industry: Household & Personal Products
CEO: Mr. Thibaut Mongon
Sector: Consumer Defensive
Employees: 22000
Address: 199 Grandview Road, Skillman, NJ 08558
Phone: (732) 524-0400
Leadership
- Kathleen M. Pawlus, Independent Director
- Kirk L. Perry, Independent Director
Last updated: 2024-12-31
OptimizeRx Corporation
Mobile Health Messenger platform
Optimize Rx Corporation is a digital health technology company offering solutions like financial messaging, virtual patient support centers, and brand support services for life sciences organizations, healthcare providers, and patients.
Leadership | Contact | Careers | About | About | Contact | About | About | About | About | About | About | About
Symbol: OPRX
Recent Price: $5.28
Industry: Medical - Healthcare Information Services
CEO: Mr. William J. Febbo
Sector: Healthcare
Employees: 135
Address: 400 Water Street, Rochester, MI 48307
Phone: 248 651 6568
Leadership
- William J. Febbo, Director
- Steve Silvestro, President
- Theresa Greco, Chief Commercial Officer
- Edward Stelmakh, Chief Financial Officer & Chief Operational Officer
- Marion Odence-Ford, Chief Compliance Officer & General Counsel
- Doug Besch, Chief Product Officer
- Brian McCarthy, Chief Revenue Officer
- Lynn O'Connor Vos, Chairperson of the Board
- Catherine Klema, Director
- James Lang, Director
- Patrick Spangler, Director
- Greg Wasson, Director
Last updated: 2024-12-31
NRx Pharmaceuticals, Inc.
ZYESAMI, NRX-100, NRX-101
NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases.
Symbol: NRXP
Recent Price: $1.53
Industry: Biotechnology
CEO: Dr. Jonathan C. Javitt M.D., M.P.H.
Sector: Healthcare
Employees: 2
Address: 1201 Orange Street, Wilmington, DE 19801
Phone: 484 254 6134
Last updated: 2024-12-31
Organon & Co.
Nexplanon/Implanon
Organon & Co. is a health care company providing solutions in women's health, biosimilars, cardiovascular, respiratory, and dermatology through a variety of products including long-acting reversible contraceptives, immunology and oncology biosimilars, and treatments for cholesterol, hypertension, asthma, and allergic rhinitis.
Leadership | Directors | ESG | ESG | Vision/Values | About | About | Locations | Contact | About | Careers | About | About | Culture | About | About | About | About | About | About | About
Symbol: OGN
Recent Price: $14.64
Industry: Drug Manufacturers - General
CEO: Mr. Kevin Ali
Sector: Healthcare
Employees: 10000
Address: 30 Hudson Street, Jersey City, NJ 07302
Phone: 551 430 6000
Last updated: 2024-12-31
Glaukos Corporation
i Stent, i Stent inject, i Stent inject W, i Stent Infinite, i Dose TR
Glaukos Corporation is a medical technology and pharmaceutical company developing therapies for glaucoma, corneal disorders, and retinal diseases. It offers micro-bypass stents and injectable implants intended to improve intraocular treatment.
Foundation | About | About | History | Foundation | Awards | About | Contact | Sustainability | Careers | Careers | About | About | About | About | About | About | Jobs
Symbol: GKOS
Recent Price: $149.51
Industry: Medical - Devices
CEO: Mr. Thomas William Burns
Sector: Healthcare
Employees: 907
Address: 229 Avenida Fabricante, San Clemente, CA 92672
Phone: 949 367 9600
Last updated: 2024-12-31
Aclaris Therapeutics, Inc.
Zunsemetinib
Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immune-inflammatory diseases. It operates through Therapeutics and Contract Research segments, addressing unmet needs with innovative therapies, including treatments for rheumatoid and psoriatic arthritis, atopic dermatitis, autoimmune diseases, inflammatory bowel disease, and certain cancers.
Contact | Careers | About | About | Directors | Leadership | About | Careers | About | About | Jobs
Symbol: ACRS
Recent Price: $2.48
Industry: Medical - Diagnostics & Research
CEO: Dr. Neal S. Walker D.O., M.D.
Sector: Healthcare
Employees: 86
Address: 640 Lee Road, Wayne, PA 19087
Phone: 484 324 7933
Last updated: 2024-12-31
Clearside Biomedical, Inc.
XIPERE
Clearside Biomedical, Inc. is a biopharmaceutical company focused on revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. They offer treatments such as XIPERE for uveitis macular edema and are developing additional therapies for ocular conditions.
Symbol: CLSD
Recent Price: $0.99
Industry: Biotechnology
CEO: Dr. George M. Lasezkay J.D., Pharm.D., Pharma.D.
Sector: Healthcare
Employees: 30
Address: 900 North Point Parkway, Alpharetta, GA 30005
Phone: 678 270 3631
Last updated: 2024-12-31
CareMax, Inc.
Care Optimize
Care Max, Inc. provides a range of medical and social services including primary care, specialty care, and proprietary software tools for physicians across the United States.
Symbol: CMAX
Recent Price: $0.42
Industry: Medical - Healthcare Information Services
CEO: Mr. Carlos A. de Solo
Sector: Healthcare
Employees: 1450
Address: 1000 NW 57 Court, Miami, FL 33126
Phone: 786 360 4768
Last updated: 2024-12-31
Ocular Therapeutix, Inc.
Re Sure Sealant; DEXTENZA; OTX-TKI; OTX-TIC; OTX-CSI
Ocular Therapeutix is a biopharmaceutical company that develops and commercializes therapies for eye diseases using bioresorbable hydrogel-based technology, offering products like Re Sure Sealant and DEXTENZA.
About | About | Leadership | Directors | Contact | Careers | Benefits | Vision/Values | DEI | Careers | About | About | About | About | About | About | About | About | About | About
Symbol: OCUL
Recent Price: $8.35
Industry: Biotechnology
CEO: Dr. Pravin U. Dugel M.D.
Sector: Healthcare
Employees: 267
Address: 24 Crosby Drive, Bedford, MA 01730
Phone: 781 357 4000
Leadership
- Pravin U. Dugel, MD, Executive Chairman, President and CEO
- Karen-Leigh Edwards, PhD, MBA, Chief Operations Officer
- Peter Jarrett, PhD, Chief Technical Officer
- Donald Notman, Chief Financial Officer and Chief Operating Officer
- Nadia K. Waheed, MD, MPH, Chief Medical Officer
- Jeffrey S. Heier, MD, Chief Scientific Officer
- Steve Meyers, Chief Commercial Officer
- Tracy Smith, Vice President, Human Resources
- Sanjay Nayak, MBBS, PhD, Chief Strategy Officer
- Peter K. Kaiser, MD, Chief Development Officer
- Todd Anderman, JD, Chief Legal Officer and Corporate Secretary
- Charles Warden, Lead Independent Director
- Adrienne Graves, PhD, Director
- Leslie Williams, Director
- Richard Lindstrom, MD, Director
- Seung Suh Hong, PhD, Director
- Merilee Raines, Director
Last updated: 2024-12-31
Ocuphire Pharma, Inc.
Nyxol
Ocuphire Pharma, Inc. is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of refractive and retinal eye disorders.
Symbol: OCUP
Recent Price: $1.17
Industry: Biotechnology
CEO: Mr. George Magrath M.B.A., M.D., M.S.
Sector: Healthcare
Employees: 14
Address: 37000 Grand River Avenue, Farmington Hills, MI 48335
Phone: 248 681 9815
Last updated: 2024-12-31
OptiNose, Inc.
XHANCE
Opti Nose, Inc. is a specialty pharmaceutical company focused on developing and commercializing products for ear, nose, throat, and allergy specialists in the U.S. Their products include XHANCE for chronic rhinosinusitis with nasal polyps, and Onzetra Xsail, with ongoing developments like OPN-019.
Symbol: OPTN
Recent Price: $0.41
Industry: Drug Manufacturers - Specialty & Generic
CEO: Dr. Ramy A. Mahmoud M.D., M.P.H.
Sector: Healthcare
Employees: 132
Address: 1020 Stony Hill Road, Yardley, PA 19067
Phone: 267 364 3500
Leadership
- Ramy A. Mahmoud, MD, MPH, CEO
- Paul Spence, Chief Commercial Officer
- Terry Kohler, Chief Financial Officer
- Mike Marino, Chief Legal Officer
- Anthony Krick, Chief Accounting Officer
- John Messina, PharmD, Senior Vice President, Clinical Development and Medical Affairs
- Michael C. Berkey, Vice President, Technical Operations
- Karen E. Brophy, Chief Human Resources Officer
- Ramona Lloyd, PhD, RAC, Senior Vice President, Regulatory & Quality
- Jonathan Neely, Vice President, Investor Relations, and Business Development
- R. John Fletcher, Chairman
- Wilhelmus Groenhuysen, Chief Operating Officer
- Sandra L. Helton, Director
- Catherine E. Owen, Director
- Tomas J. Heyman, Director
- Dr. Eric Bednarski, Director
- Dr. Kyle Dempsey, Director
Last updated: 2024-12-31
Outlook Therapeutics, Inc.
ONS-5010
Outlook Therapeutics, Inc. is a late clinical-stage biopharmaceutical company focused on developing and commercializing monoclonal antibodies for ophthalmic indications, with its lead product candidate ONS-5010 in Phase-III clinical trial for treating wet age-related macular degeneration and other retina diseases.
About | About | Leadership | Directors | About | Contact | Careers | Careers | Careers | Jobs | About | About
Symbol: OTLK
Recent Price: $1.86
Industry: Biotechnology
CEO: Mr. C. Russell Trenary III
Sector: Healthcare
Employees: 24
Address: Building F, Iselin, NJ 08852
Phone: 609 619 3990
Leadership
- Randy Thurman, Executive Chairman
- Yezan Haddadin, Member of the Board of Directors
- Kurt J. Hilzinger, Member of the Board of Directors
- Julia A. Haller, MD, Member of the Board of Directors
- C. Russell Trenary III, President, Chief Executive Officer, and Member of the Board
- Lawrence A. Kenyon, Chief Financial Officer and Member of the Board
- Faisal G. Sukhtian, Executive Director
- Julian Gangolli, Member of the Board of Directors
- Gerd Auffarth, MD, Member of the Board of Directors
- Andong Huang, Vice President, Business Development
Last updated: 2024-12-31
Phio Pharmaceuticals Corp.
INTASYL therapeutic platform
Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics using its INTASYL therapeutic platform to target tumor and immune cells by regulating genes of the immune system, focusing on products like PH-762, PH-894, and PH-804 for enhancing cancer immunotherapies in adoptive cell transfer.
Symbol: PHIO
Recent Price: $1.90
Industry: Biotechnology
CEO: Mr. Robert J. Bitterman
Sector: Healthcare
Employees: 8
Address: 257 Simarano Drive, Marlborough, MA 01752
Phone: 508 767 3861
Last updated: 2024-12-31
Quince Therapeutics, Inc.
NOV004
Quince Therapeutics, Inc., a biopharmaceutical company, focuses on advancing precision therapeutics for debilitating and rare diseases, with a bone-targeting drug platform and lead compound NOV004 designed to target bone fracture and disease sites.
Symbol: QNCX
Recent Price: $1.85
Industry: Biotechnology
CEO: Dr. Dirk Thye M.D.
Sector: Healthcare
Employees: 32
Address: 601 Gateway Blvd, South San Francisco, CA 94080
Phone: 415 910 5717
Last updated: 2024-12-31
Quoin Pharmaceuticals, Ltd.
QRX003
Quoin Pharmaceuticals, Ltd. is a specialty pharmaceutical company focused on developing therapeutic products for rare and orphan diseases, including QRX003 for Netherton Syndrome.
Symbol: QNRX
Recent Price: $0.70
Industry: Biotechnology
CEO: Dr. Michael Myers Ph.D.
Sector: Healthcare
Employees: 4
Address: 42127 Pleasant Forest Court, Ashburn, VA 20148-7349
Phone: 703 980 4182
Last updated: 2024-12-31
Nuvectis Pharma, Inc.
NXP800, NXP900
Nuvectis Pharma, Inc., is a biopharmaceutical company that focuses on developing precision medicines for treating serious unmet medical needs in oncology. It is working on products like NXP800, a heat shock factor 1 pathway inhibitor, and NXP900, a drug candidate targeting Proto-oncogene c-Src and YES1 kinases.
Symbol: NVCT
Recent Price: $5.14
Industry: Biotechnology
CEO: Mr. Ron Bentsur M.B.A.
Sector: Healthcare
Employees: 13
Address: 1 Bridge Plaza, Fort Lee, NJ 07024
Phone: 201 614 3150
Last updated: 2024-12-31